PFBC Preferred Bank posts narrow Q1 2026 EPS miss shares rise 161 percent as investors overlook the shortfall Regeneron Pharmaceuticals REGN Bullish Investment Case Strengthens Post FDA Hearing Gene Therapy Approval Amid Temporary Share Pullback iShares MSCI Japan ETF EWJ Rallies Amid Broad US Dollar Reversal and Global Risk Asset Surge How 2020 Biolabs AIDX integrates its acquisitions AIDX Latest Quarter Earnings 2020 Biolabs withholds core EPS and revenue performance metrics